Commercial Insurance Company
Dr. Goran Jezic, MD
Physical Medicine & Rehabilitation*
Age 60
Be the first to review this provider!
Dr. Goran Jezic, MD
Be the first to review this provider!
Houston, TX
Accepting new patients
Clinical Overview
Dr. Goran Jezic, MD works in Houston, TX as
COMPARE OTHER TOP Physiatrists
Contrast Dr. Jezic with other nearby specialists practicing at HCA Houston Healthcare North Cypress.
Make an appointment at HCA Houston Healthcare North Cypress today at 832-669-3903.
Make an appointment at HCA Houston Healthcare North Cypress today at 832-669-3903.
These providers are on the medical staff of HCA Houston Healthcare North Cypress.
Advertisement
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
Choice Plus POS IIAetna HMO
-
Blue Advantage HMOBlue Choice
-
Choice Care PPOPreferred PPO
-
National (BlueCard) PPO
-
Blue Card PPO
Office Locations
-
Regen Med PLLC4101 Greenbriar Dr Ste 200, Houston, TX 77098
-
Gulf Coast Spine Care LTD. PA1200 Binz St Ste 970, Houston, TX 77004
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Dr. Jezic?
Step 1 of 3
Your review of Dr. Goran Jezic, MD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Languages Spoken
Croatian
Serbo-Croatian
Spanish
Specialties*
Physical Medicine & Rehabilitation
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Dr. Goran Jezic, MD accepts new patients on Medical News Today.
Dr. Jezic accepts Commercial Insurance Company, Aetna, Blue Cross and Blue Shield of Texas, Humana, Anthem and Blue Cross Blue Shield as well as many others. See all of the insurances Dr. Jezic accepts here.
Dr. Jezic's office is located at 4101 Greenbriar Dr Ste 200 Houston, TX 77098. Get a map and directions to Dr. Jezic's office here.
Yes, Dr. Jezic speaks Croatian, Serbo-Croatian and Spanish. See Dr. Jezic's profile on MedicalNewsToday for more information.
Dr. Jezic does not have any reviews yet.
Dr. Jezic is board certified in
Education & Credentials
Medical Education
- University of Texas at Tyler School of Medicine
Board Certifications
- Physical Medicine & Rehabilitation
Internship
-
University Tex Health Sci Center
1993
Residency Hospital
- University of Utah
Claim Your Profile
Are you Dr. Goran Jezic, MD?
Affiliated Hospitals & Medical Centers
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
The FDA has approved Moderna's new mRNA flu vaccine for adults ages 50 years and older. Moderna expects the vaccine to be available in the United States for the 2026 to 2027 flu season.
A natural compound derived from plant foods containing a certain type of polyphenol may help improve heart function in people with heart failure, a study in animals and human tissue models has found.
Moderna and Merck's neoantigen treatment, combining a personalized mRNA cancer vaccine with the immunotherapy drug pembrolizumab significantly reduced the risk of melanoma recurrence in a phase 3 trial.
